Trade Secret Applications for Canada
By: Kirsten Alcock, Manager of Product Safety, email The Hazardous Products Regulations (HPR) dictates what information must be available on a SDS within each prescribed section. The SDS is [...]
Advertising Your Test Market Product in Canada
By: Teri Dickinson, Regulatory Affairs Group Manager, email Advertising material includes any promotional material in print, on television, radio, the Internet, and in any other medium (social [...]
Registering a Hand Sanitizer in Canada
By: Sarah Calder, Regulatory Affairs Specialist, email Does a hand sanitizer require pre-approval in Canada before going to market? Hand sanitizers, hand sanitizing wipes, and antibacterial hand [...]
Does Your Product Contain Methylene Diphenyl Diisocyanates (MDI)?
By: Ivy Tang, Product Safety Specialist, email In May 2019, five MDIs (methylene diphenyl diisocyanates) were added to Schedule 1 of the List of Toxic Substances of the Canadian Environmental [...]
Health Products Compliance Monitoring
By: Sarah Calder, Regulatory Affairs Specialist, email Importers, manufacturers, and distributors of health products regulated under the Food and Drugs Act who advertise in Canada must ensure [...]
Consequences of a Non-Compliant Consumer Label
By: Ivy Tang, Product Safety Specialist, email Under the Canada Consumer Product Safety Act (CCPSA), it is prohibited to manufacture, import, or sell a consumer product that is dangerous to human [...]
Are You in Violation of the Hazardous Products Regulations (HPR)? Is Your Safety Data Sheet (SDS) Compliant?
By: Kirsten Alcock, Manager of Product Safety, email When the Globally Harmonized System (GHS) regulations came into effect in Canada, the three year renewal period was abolished FEDERALLY. As I [...]
Fees for Human, Disinfectant, and Over-the-Counter Drugs
By: Teri Dickinson, Regulatory Affairs Group Manager, email Are you ready for Cost Recovery implementation coming into force on April 1, 2020? You may want to get your submissions in now. After [...]
Medical Devices: Evaluation and Right to Sell Fees
By: Teri Dickinson, Regulatory Affairs Group Manager, email Are you ready for Cost Recovery implementation coming into force on April 1, 2020? Starting April 1, 2020, new medical device [...]
Veterinary Drugs (Evaluation and Right to Sell Fees)
By: Teri Dickinson, Regulatory Affairs Group Manager, email Are you ready for Cost Recovery implementation coming into force on April 1, 2020? You may want to get your submissions in now. Other [...]
